Search This Blog

Saturday, January 1, 2022

iTeos Therapeutics Set to Join S&P SmallCap 600

  iTeos Therapeutics Inc. (NASD: ITOS) will replace Magellan Health Inc. (NASD: MGLN) in the S&P SmallCap 600 effective prior to the opening of trading on Wednesday, January 5. S&P 500 constituent Centene Corp. (NYSE: CNC) is acquiring Magellan Health in a deal expected to be completed soon pending final conditions.

Following is a summary of the changes that will take place prior to the open of trading on the effective date:

Effective Date

Index Name

Action

Company Name

Ticker

GICS Sector

January 5, 2022

S&P SmallCap 600

Addition

iTeos Therapeutics

ITOS

Health Care


S&P SmallCap 600

Deletion

Magellan Health

MGLN

Health Care

For more information about S&P Dow Jones Indices, please visit www.spdji.com

https://finance.yahoo.com/news/iteos-therapeutics-set-join-p-224400392.html

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.